The Rise and Fall of 23andMe

This chapter examines the decline of 23andMe, focusing on the company's journey from a burgeoning biotech startup to filing for bankruptcy. The speakers discuss the implications of genetic testing, consumer engagement, and the evolving landscape of health-related services. Additionally, they humorously explore the emerging field of humanoid robots, emphasizing the potential for technology to assist in daily life.